New: NCI-funded clinical trial search
Mednet Logo

Do you perform a bone health assessment in men who will be receiving short term androgen deprivation for localized prostate cancer?

If so, does it differ from the assessment you would perform in men receiving long term ADT?
Community PollStarted

What do you do if a patient you are treating with AD also has osteoporosis?

38 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer
Mednet MemberInvited Expert
Radiation Oncology · Rutgers Cancer Institute of New Jersey
Answered on

I do not order bone densitometry on patients I am treating with short term (<= 6 months) of AD, unless they have a risk factor like long-term glucocorticoid use or prior fracture. For patients I am treating with long term >=18 months I perform a baseline bone densitometry. If that is normal-mild osteopenia, I repeat it in 2 years if they remain on AD or if their testosterone remains suppressed despite discontinuation of AD. If the baseline bone densitometry showed significant osteopenia, I would repeat in one year instead of two. I decide to treat using the FRAX website to estimate the risk of fracture https://www.sheffield.ac.uk/FRAX/

Join for free or sign in to see the full answer